# OnCo record paper-nadina-nejm-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-nadina-nejm-2024" ;
schema:name "NADINA: two doses of ipilimumab plus nivolumab before surgery beat a year of nivolumab after surgery in stage III melanoma"@en ;
schema:description "Giving just two cycles of combination immunotherapy before removing melanoma lymph nodes cut relapses by more than two-thirds compared with a year of standard immunotherapy after surgery, and most patients needed no further treatment."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2024"^^xsd:gYear ;
schema:author "Blank CU, Lucas MW, Scolyer RA, et al." ;
onco:cancers ;
onco:technologies ;
onco:targets , ;
onco:drugs , ;
onco:companies ;
onco:institutions ;
onco:terms , , , ;
onco:people , ;
onco:bottlenecks , , , ;
onco:journals .